Advertisement

Chemistry of Natural Compounds

, Volume 55, Issue 4, pp 716–718 | Cite as

Neoflavonoid Angelicin Derivatives

  • T. V. ShokolEmail author
  • V. S. Moskvina
  • E. K. Glebov
  • V. P. Khilya
Article
  • 7 Downloads

Furocoumarins form one of the most important classes of natural flavonoids with photosensitizing action that are used therapeutically for psoriasis, fungal mycosis, and cancer [1, 2]. The simplest angular furocoumarin angelicin (isopsoralen) occurs in plants of the family Apiaceae [3] and exhibits antioxidant, anti-inflammatory, membrane-stabilizing, and anabolic activity [4]. 4-Alkyl-8-aroyl-9-arylangelicin derivatives exhibited antiviral activity against influenza A (H1N1) [5] and were patented as agents for cancer treatment [6]. Natural neoflavanoid angelicin derivatives and their analogs with hydrogenated furan rings were isolated from bark of Ochrocarpos punctatus and Mammea neurophylla [7, 8, 9]. Furanoracemosone was isolated from leaves of Mesua racemosa [10]; its analogs, from bark and fruit of Calophyllum dispar [11].

Two approaches were previously used to synthesize 4-phenylfuro[2,3-h]coumarins, i.e., annelation of an α-pyrone ring to benzofuran via intramolecular...

References

  1. 1.
    R. Gambari, I. Lampronti, N. Bianchi, C. Zuccato, G. Viola, D. Vedald, and F. Dall’Acqua, Bioact. Heterocycl. III, 265 (2007).Google Scholar
  2. 2.
    L. Santana, E. Uriarte, F. Roleira, N. Milhazes, and F. Borges, Curr. Med. Chem., 11 (24), 3239 (2004).CrossRefGoogle Scholar
  3. 3.
    W. Steck and B. K. Bailey, Can. J. Chem., 47 (13), 2425 (1969).CrossRefGoogle Scholar
  4. 4.
    A. M. Komisarenko, S. M. Komisarenko, and I. F. Sotsiperova, Visn. Farm., No. 3–4, 99 (1995).Google Scholar
  5. 5.
    J.-Y. Yeh, M. S. Coumar, J.-T. Horng, H.-Y. Shiao, F.-M. Kuo, H.-L. Lee, I.-C. Chen, C.-W. Chang, W.-F. Tang, S.-N. Tseng, C.-J. Chen, S.-R. Shih, J. T.-A. Hsu, C.-C. Liao, Y.-S. Chao, and H.-P. Hsieh, J. Med. Chem., 53 (4), 1519 (2010).CrossRefGoogle Scholar
  6. 6.
    US Pat. 312,317 (2009).Google Scholar
  7. 7.
    V. S. P. Chaturvedula, J. K. Schilling, and D. G. I. Kingston, J. Nat. Prod., 65, 965 (2002).CrossRefGoogle Scholar
  8. 8.
    Y.-W. Chin, K. D. Yoon, and J. Kim, Anti-Cancer Agents Med. Chem., 9, 913 (2009).CrossRefGoogle Scholar
  9. 9.
    B. T. Dang, Y. Guition, I. Freuze, O. Groevel, M. Litaudon, P. Richomme, D. Seraphin, and S. Derbre, Phytochem. Lett., 11, 61 (2015).CrossRefGoogle Scholar
  10. 10.
    C. Morel, C. Dartiguelongue, T. Youhana, J.-M. Oger, D. Seraphin, O. Duval, P. Richomme, and J. Bruneton, Heterocycles, 51, 2183 (1999).CrossRefGoogle Scholar
  11. 11.
    D. Guilet, J.-J. Heles beux, D. Seraphin, T. Sevenet, P. Richomme, and J. Bruneton, J. Nat. Prod., 64, 563 (2001).CrossRefGoogle Scholar
  12. 12.
    T. Kitamura and K. Otsubo, J. Org. Chem., 77, 2978 (2012).CrossRefGoogle Scholar
  13. 13.
    S. M. Desai and K. N. Trivedi, Indian J. Chem., Sect B: Org. Chem. Incl. Med. Chem., 24, 47 (1985).Google Scholar
  14. 14.
    D. B. Limaye, R. H. Munje, G. S. Shenolikar, and S. S. Talwalkar, Rasayanam 1, 187 (1939); Chem. Abstr., 34, 5071 (1940).Google Scholar
  15. 15.
    V. S. Moskvina and V. P. Khilya, Chem. Nat. Compd., 44, 16 (2008).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  • T. V. Shokol
    • 1
    Email author
  • V. S. Moskvina
    • 1
  • E. K. Glebov
    • 1
  • V. P. Khilya
    • 1
  1. 1.Taras Shevchenko National University of KyivKievUkraine

Personalised recommendations